Answers are grounded in this paper and cite their sources.
In a double reversal design the potency of thyrotropin releasing hormone (TRH) (500 mug intravenously) as a quick-acting antidepressive agent was evaluated. A first injection did seem to give rise to a very slight short-lasting effect, though this could not be ascertained clearly. There were no visible effects after a second injection. The thyroid stimulating hormone (TSH) response curve after TRH administration in the depressive patients group was blunted in comparison with that in a matched control group of normals.
No takes yet. Share an insight, caveat, or question.
Burg et al. (1975) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: